mhurhangee/ep-ind-claims huggingface dataset:
A method of manufacturing a light emitting device, comprising: providing a substrate (140, 250); forming a plurality of photosensitive bumps over the substrate (140, 250); forming a photosensitive layer (251, 254, 302) over the plurality of photosensitive bumps; said method characterized by further comprising: forming a buffer layer between the photosensitive layer (251, 254, 302) and the plurality of photosensitive bumps; patterning the photosensitive layer (251, 254, 302) and the buffer layer to form a recess (312, 313) through the photosensitive layer (251, 254, 302) and the buffer layer to expose a surface; disposing an organic emissive layer on the surface, forming a metal containing layer over the organic emissive layer, and removing the patterned photosensitive layer (251, 254, 302) and the remaining portion of the buffer layer. providing a substrate (140, 250); forming a plurality of photosensitive bumps over the substrate (140, 250); forming a photosensitive layer (251, 254, 302) over the plurality of photosensitive bumps; said method characterized by further comprising: forming a buffer layer between the photosensitive layer (251, 254, 302) and the plurality of photosensitive bumps; patterning the photosensitive layer (251, 254, 302) and the buffer layer to form a recess (312, 313) through the photosensitive layer (251, 254, 302) and the buffer layer to expose a surface; disposing an organic emissive layer on the surface, forming a metal containing layer over the organic emissive layer, and removing the patterned photosensitive layer (251, 254, 302) and the remaining portion of the buffer layer. forming a buffer layer between the photosensitive layer (251, 254, 302) and the plurality of photosensitive bumps; patterning the photosensitive layer (251, 254, 302) and the buffer layer to form a recess (312, 313) through the photosensitive layer (251, 254, 302) and the buffer layer to expose a surface; disposing an organic emissive layer on the surface, forming a metal containing layer over the organic emissive layer, and removing the patterned photosensitive layer (251, 254, 302) and the remaining portion of the buffer layer.
A method of assisting transducer placements on a subject's body for applying tumor treating fields, the method comprising: determining, based on one or more images associated with a portion of a subject's body, first image data, wherein the first image data comprises one or more transducer placement positions; determining, based on the one or more images, second image data, wherein the second image data comprises one or more recommended transducer placement positions; registering the first image data to the second image data; and generating composite data (1206; 1207) comprising the one or more transducer placement positions and the one or more recommended transducer placement positions. determining, based on one or more images associated with a portion of a subject's body, first image data, wherein the first image data comprises one or more transducer placement positions; determining, based on the one or more images, second image data, wherein the second image data comprises one or more recommended transducer placement positions; registering the first image data to the second image data; and generating composite data (1206; 1207) comprising the one or more transducer placement positions and the one or more recommended transducer placement positions.
In vitro method for diagnosing subjects infected with Mycobacterium species which comprises: a) Measuring the concentration of the protein ABCA13 in a biological sample consisting of serum or plasma obtained from the subject, and b) Wherein if an increase of the concentration of the protein ABCA13 is identified in the step a) with respect to the concentration of the protein ABCA13 measured in uninfected control subjects, it is an indication that the subject is infected with Mycobacterium species. a) Measuring the concentration of the protein ABCA13 in a biological sample consisting of serum or plasma obtained from the subject, and b) Wherein if an increase of the concentration of the protein ABCA13 is identified in the step a) with respect to the concentration of the protein ABCA13 measured in uninfected control subjects, it is an indication that the subject is infected with Mycobacterium species.
A tap hole maintenance device for cleaning the bottom tap hole of an electric arc furnace, which electric arc furnace comprises a furnace vessel having a furnace lower vessel with an eccentric or offset bottom tap hole having a minimum diameter along a longitudinal axis thereof, and a furnace tilting device comprising a cradle, on which the furnace vessel is supported, for tilting the furnace vessel relative to the horizontal of a foundation, on which the electric arc furnace is supported, which tap hole maintenance device comprises - a pivot arm that is adapted to be pivoted between a parking position and a maintenance position, and - a lance attached to an end portion of the pivot arm and extending along a longitudinal axis, wherein the lance comprises a lance head, which lance head is movable along the longitudinal axis of the lance between a lower end position and an upper end position and which lance head comprises an outer diameter which is smaller than the minimum diameter of the bottom tap hole and which lance head comprises lateral oxygen outlet nozzles (31, 32, 33) with an outlet angle oblique downwards to the longitudinal axis of the lance, preferably with an outlet angle in the range of 30° to 60°, preferably 45°, and which lance is adapted for attachment to the furnace vessel and/or to the cradle in such a way that it is movable together with the furnace vessel when the latter is tilted and the lance is located under the tap hole with the longitudinal axis of the lance being coaxial with the longitudinal axis of the tap hole in the maintenance position of the pivot arm, so that the lance head is movable through the tap hole during movement between its lower end position and its upper end position. - a pivot arm that is adapted to be pivoted between a parking position and a maintenance position, and - a lance attached to an end portion of the pivot arm and extending along a longitudinal axis,
Ophthalmological multi-wavelength laser system with an optical waveguide system, comprising: at least one multi-wavelength laser system, comprising: a first semiconductor diode laser (10.1) with a first working beam (20.1) which has a first wavelength λ 1 and at least one second semiconductor diode laser (10.2) with a second working beam (20.2) which has a second wavelength λ 2, wherein the optical waveguide system is a fibre-optic system which comprises at least two optical fibres in which the working beams (20.1, 20.2) are guided, which are coupled to an optical fibre, wherein the working beams (20.1, 20.2) of the multi-wavelength laser system are coupled into the optical waveguide system at the same or at different points of the optical fibre of the fibre-optic system and wherein the beam path of the working beams (20.1, 20.2) is thereby not exposed and the working beams can be propagated up to one end of the optical fibre. at least one multi-wavelength laser system, comprising: a first semiconductor diode laser (10.1) with a first working beam (20.1) which has a first wavelength λ 1 and at least one second semiconductor diode laser (10.2) with a second working beam (20.2) which has a second wavelength λ 2, wherein the optical waveguide system is a fibre-optic system which comprises at least two optical fibres in which the working beams (20.1, 20.2) are guided, which are coupled to an optical fibre, wherein the working beams (20.1, 20.2) of the multi-wavelength laser system are coupled into the optical waveguide system at the same or at different points of the optical fibre of the fibre-optic system and wherein the beam path of the working beams (20.1, 20.2) is thereby not exposed and the working beams can be propagated up to one end of the optical fibre. a first semiconductor diode laser (10.1) with a first working beam (20.1) which has a first wavelength λ 1 and at least one second semiconductor diode laser (10.2) with a second working beam (20.2) which has a second wavelength λ 2, wherein the optical waveguide system is a fibre-optic system which comprises at least two optical fibres in which the working beams (20.1, 20.2) are guided, which are coupled to an optical fibre, wherein the working beams (20.1, 20.2) of the multi-wavelength laser system are coupled into the optical waveguide system at the same or at different points of the optical fibre of the fibre-optic system and wherein the beam path of the working beams (20.1, 20.2) is thereby not exposed and the working beams can be propagated up to one end of the optical fibre.
A method for hydrolytic cleavage of zearalenone and/or at least one zearalenone derivative by means of a hydrolytically cleaving polypeptide, characterized in that the zearalenone and/or at least one zearalenone derivative is hydrolysed by the polypeptide, which is a hydrolase having an amino acid sequence selected from the group of sequence ID numbers 2 to 6, in particular the sequence ID No. 6 or a functional variant thereof, wherein a sequence identity of at least 70 % exists between the functional variant and the amino acid sequence.
A system for determining force balance on a knee joint during a surgical procedure, the system comprising: a tibial prosthesis including a base component and a set of shim components (346, 346A, 346B, 346C, 346D, 858, 860, 862, 864, 880), the base component having a superior surface and an inferior surface, characterised in that the tibial prosthesis includes a bearing component having a superior articulating surface and an inferior surface comprising a plurality of sensors, and in that at least one shim in the set of shim components includes one or both of a medial edge having a different height than a lateral edge or an anterior edge having a different height than a posterior edge, and one or more shims are selected for insertion between the inferior surface of the bearing component and the superior surface of the base component in an anterior/posterior direction, based on a proximal/distal spacing between the bearing component and the base component. a tibial prosthesis including a base component and a set of shim components (346, 346A, 346B, 346C, 346D, 858, 860, 862, 864, 880), the base component having a superior surface and an inferior surface, characterised in that the tibial prosthesis includes a bearing component having a superior articulating surface and an inferior surface comprising a plurality of sensors, and in that at least one shim in the set of shim components includes one or both of a medial edge having a different height than a lateral edge or an anterior edge having a different height than a posterior edge, and one or more shims are selected for insertion between the inferior surface of the bearing component and the superior surface of the base component in an anterior/posterior direction, based on a proximal/distal spacing between the bearing component and the base component.
A microfluidic circuit comprising: an input valve; one or more holding chambers (102, 302a-d, 404, 2004) in fluid communication with the input valve; a mixing circuit (104, 304a-d, 402, 406, 2008, 5300); and one or more sieve valves (108, 200, 250, 504, 1500, 1700, 2006, 5100) positioned between the holding chamber (102, 302a-d, 404, 2004) and the mixing circuit (104, 304a-d, 402, 406, 2008), and a plurality of sieve valves (108, 5100) positioned in series on the mixing circuit (104, 5300), wherein the sieve valves (108, 200, 250, 504, 1500, 1700, 2006, 5100) comprise a substrate (1502, 1702, 5102) defining a channel (1504, 1704, 1904, 5104); a flexible membrane (1506, 1706, 5106) adapted and configured for deployment at an intersection with the channel; and one or more protrusions (1508, 1708, 1908, 5108) extending into the channel from the substrate or the flexible membrane, the one or more protrusions defining a plurality of recesses (1912, 5112) extending beyond the intersection between the channel and the flexible membrane; and, optionally, further comprising: a pressure channel extending below the flexible membrane; wherein the one or more holding chambers (102, 302a-d, 404, 2004) is configured to store or trap a capture substrate. an input valve; one or more holding chambers (102, 302a-d, 404, 2004) in fluid communication with the input valve; a mixing circuit (104, 304a-d, 402, 406, 2008, 5300); and one or more sieve valves (108, 200, 250, 504, 1500, 1700, 2006, 5100) positioned between the holding chamber (102, 302a-d, 404, 2004) and the mixing circuit (104, 304a-d, 402, 406, 2008), and a plurality of sieve valves (108, 5100) positioned in series on the mixing circuit (104, 5300), wherein the sieve valves (108, 200, 250, 504, 1500, 1700, 2006, 5100) comprise a substrate (1502, 1702, 5102) defining a channel (1504, 1704, 1904, 5104); a flexible membrane (1506, 1706, 5106) adapted and configured for deployment at an intersection with the channel; and one or more protrusions (1508, 1708, 1908, 5108) extending into the channel from the substrate or the flexible membrane, the one or more protrusions defining a plurality of recesses (1912, 5112) extending beyond the intersection between the channel and the flexible membrane; and, optionally, further comprising: a pressure channel extending below the flexible membrane; wherein the one or more holding chambers (102, 302a-d, 404, 2004) is configured to store or trap a capture substrate. a substrate (1502, 1702, 5102) defining a channel (1504, 1704, 1904, 5104); a flexible membrane (1506, 1706, 5106) adapted and configured for deployment at an intersection with the channel; and one or more protrusions (1508, 1708, 1908, 5108) extending into the channel from the substrate or the flexible membrane, the one or more protrusions defining a plurality of recesses (1912, 5112) extending beyond the intersection between the channel and the flexible membrane; and, optionally, further comprising: a pressure channel extending below the flexible membrane; wherein the one or more holding chambers (102, 302a-d, 404, 2004) is configured to store or trap a capture substrate.
A system to determine an early battery depletion condition for a battery powered medical device, the system comprising: a processor (1220, 1302); memory (1260, 1304, 1306, 1308) storing program instructions accessible by the processor (1220, 1302); characterized in that, responsive to execution of the program instructions, the processor (1220, 1302) is configured to: determine, based on a value of the current drawn from a battery cell by the medical device, a charge consumption drawn externally from the battery cell by the medical device for a select period of time; obtain a measured cell voltage for the battery cell of the medical device; calculate an estimated cell voltage based on the charge consumption; and declare an early depletion condition based on a relation between the measured and estimated cell voltages. a processor (1220, 1302); memory (1260, 1304, 1306, 1308) storing program instructions accessible by the processor (1220, 1302); characterized in that, responsive to execution of the program instructions, the processor (1220, 1302) is configured to: determine, based on a value of the current drawn from a battery cell by the medical device, a charge consumption drawn externally from the battery cell by the medical device for a select period of time; obtain a measured cell voltage for the battery cell of the medical device; calculate an estimated cell voltage based on the charge consumption; and declare an early depletion condition based on a relation between the measured and estimated cell voltages. determine, based on a value of the current drawn from a battery cell by the medical device, a charge consumption drawn externally from the battery cell by the medical device for a select period of time; obtain a measured cell voltage for the battery cell of the medical device; calculate an estimated cell voltage based on the charge consumption; and declare an early depletion condition based on a relation between the measured and estimated cell voltages.
A titanium system composite, comprising: a lithium titanium composite oxide; and a lithium compound cladding the lithium titanium composite oxide; characterised by that based on the total weight of the titanium system composite, the amount of the lithium compound is 0.5 wt % to 30 wt %, and the amount of lithium titanium composite oxide is 70 wt % to 99.5 wt %. a lithium titanium composite oxide; and a lithium compound cladding the lithium titanium composite oxide; characterised by that based on the total weight of the titanium system composite, the amount of the lithium compound is 0.5 wt % to 30 wt %, and the amount of lithium titanium composite oxide is 70 wt % to 99.5 wt %.
A herbicidal composition comprising, as active ingredients, a-herbicidally active compound and a uracil compound represented by the following Formula 1 or an agrochemically acceptable salt thereof: Formula 1 wherein R 1 and R 5 represent a methyl group; R 2, R 3, and R 4 represent a hydrogen atom; X represents O, or S; Y represents a methylene group; W represents O; and Z represents a chlorine atom; wherein the X represents O and the herbicidally active compound is glyphosate or glufosinate, or wherein the X represents S and the herbicidally active compound is at least one selected from the group consisting of glyphosate, glufosinate, fenoxaprop, clodinafop, fluazifop, haloxyfop, metamifop, pinoxaden, clethodim, tralkoxydim, imazethapyr, trifloxysulfuron, bispyribac-sodium, 2,4-D, dicamba, picloram, fluroxypyr, triclopyr, MCPA, mecoprop, quinclorac, MCPB, chloridazon, bentazone, bromoxynil, propanil, isoproturon, mesosulfuron, metsulfuron, diflufenican, nicosulfuron, iodosulfuron, florasulam, mesotrione, isoxaflutole, flufenacet, sulfentrazone, carfentrazone, bensulfuron, pyrazosulfuron, azimsulfuron, Cinosulfuron, Cyclosulfamuron, Halosulfuron, Imazosulfuron, Orthosulfamuron, Pyriminobac, Pyrimisulfan, Propyrisulfuron, Metazosulfuron, Triafamone, Anilofos, Benzobicyclon, Bromobutide, Cafenstrole, Esprocarb, Ethoxysulfuron, Fentrazamide, Indanofan, Mefenacet, Molinate, Oxaziclomefone, Pyributicarb, Pyriftalid, Quinoclamine, glyphosate-isopropylammonium, glufosinate-ammonium, clopyralid, sulcotrione, clomazone, picolinafen, imazamox, diclofop-methyl, diflufenzopyr, isoxaben, asulam bilanafos, ethofumesate, atrazine, oxadiazon, acetochlor, pendimethalin, and aminopyralid. wherein R 1 and R 5 represent a methyl group; R 2, R 3, and R 4 represent a hydrogen atom; X represents O, or S; Y represents a methylene group; W represents O; and Z represents a chlorine atom; wherein the X represents O and the herbicidally active compound is glyphosate or glufosinate, or wherein the X represents S and the herbicidally active compound is at least one selected from the group consisting of glyphosate, glufosinate, fenoxaprop, clodinafop, fluazifop, haloxyfop, metamifop, pinoxaden, clethodim, tralkoxydim, imazethapyr, trifloxysulfuron, bispyribac-sodium, 2,4-D, dicamba, picloram, fluroxypyr, triclopyr, MCPA, mecoprop, quinclorac, MCPB, chloridazon, bentazone, bromoxynil, propanil, isoproturon, mesosulfuron, metsulfuron, diflufenican, nicosulfuron, iodosulfuron, florasulam, mesotrione, isoxaflutole, flufenacet, sulfentrazone, carfentrazone, bensulfuron, pyrazosulfuron, azimsulfuron, Cinosulfuron, Cyclosulfamuron, Halosulfuron, Imazosulfuron, Orthosulfamuron, Pyriminobac, Pyrimisulfan, Propyrisulfuron, Metazosulfuron, Triafamone, Anilofos, Benzobicyclon, Bromobutide, Cafenstrole, Esprocarb, Ethoxysulfuron, Fentrazamide, Indanofan, Mefenacet, Molinate, Oxaziclomefone, Pyributicarb, Pyriftalid, Quinoclamine, glyphosate-isopropylammonium, glufosinate-ammonium, clopyralid, sulcotrione, clomazone, picolinafen, imazamox, diclofop-methyl, diflufenzopyr, isoxaben, asulam bilanafos, ethofumesate, atrazine, oxadiazon, acetochlor, pendimethalin, and aminopyralid.
A resource negotiation method for device-to-device, D2D, communication, comprising: obtaining, by a second base station, an available channel resource of a first device in a case that it is determined, by a first base station and/or the second base station, that a D2D communication frequency point handoff is to be performed, wherein the first device is connected to the first base station; allocating, by the second base station, a D2D communication resource for a D2D communication between the first device and a second device based on an available channel resource of the second device connected to the second base station and the available channel resource of the first device; and notifying, by the second based station, the second device of the allocated D2D communication resource, and notifying, by the second based station, the first device of the allocated D2D communication resource via the first base station, wherein the available channel resource of the first device is an available channel list obtained by the first base station by querying the first device, wherein the second base station receives the available channel resource of the first device sent by the first base station, and wherein the available channel resource of the second device is an available channel list obtained by the second base station by querying the second device. obtaining, by a second base station, an available channel resource of a first device in a case that it is determined, by a first base station and/or the second base station, that a D2D communication frequency point handoff is to be performed, wherein the first device is connected to the first base station; allocating, by the second base station, a D2D communication resource for a D2D communication between the first device and a second device based on an available channel resource of the second device connected to the second base station and the available channel resource of the first device; and notifying, by the second based station, the second device of the allocated D2D communication resource, and notifying, by the second based station, the first device of the allocated D2D communication resource via the first base station, wherein the available channel resource of the first device is an available channel list obtained by the first base station by querying the first device, wherein the second base station receives the available channel resource of the first device sent by the first base station, and wherein the available channel resource of the second device is an available channel list obtained by the second base station by querying the second device.